The radiomics nomogram model exhibited favorable performance for differentiating low CD8+TILs from high CD8+TILs levels in the HER2-positive BC, with an AUC of 0.866 and 0.886 in the training and validation cohorts, respectively. The gene discussed is ERBB2; the disease is breast cancer.